Pharma News - Chemdiv

FDA places partial clinical hold on umbralisib and ublituximab trials in CLL and NHL

The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on a series of trials investigating the use using umbralisib in combination with ublituximab (U2) as a treatment for c...

Timber Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for TMB-001 in Moderate to Severe Congenital Ichthyosis

Timber Pharmaceuticals announced the successful completion of an End-of-Phase 2 meeting with the U.S. FDA resulting in a clear path towards a pivotal Phase 3 study for its lead asset, TMB-001, a to...

Researchers develop new approach to discover pervasive ‘forever’ chemicals known as PFAS

PFAS, a family of thousands of human-made chemicals, are everywhere, and some of them are known to be harmful for our bodies and the environment.

FDA Approves First Generic of Restasis for Dry Eye

The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis) for dry eye, a condition that affects millions of Americans each year.

A pill that releases RNA in the stomach could offer a new way to administer vaccines

Like most vaccines, RNA vaccines have to be injected, which can be an obstacle for people who fear needles.

FDA Approves Glenmark Pharmaceuticals’ Generic Metronidazole Gel

Glenmark Pharmaceuticals USA has received FDA’s approval for its generic version of MetroGel-Vaginal Gel (metronidazole) 0.75 percent made by Bausch Health.